Brigham and Women's Hospital is the largest hospital of the Longwood Medical and academic area in Boston, Massachusetts, USA. It is Harvard Medical School's second largest teaching affiliate with 793 beds. With Massachusetts General Hospital, it is one of the two founding members of Partners HealthCare, the largest healthcare provider in Massachusetts. It is specialized in providing patient care, biomedical research, and education and training programs for physicians, scientists, and health care professionals. In addition, BWH is committed to health equity and reducing disparities locally and through its numerous global health programs. BWH is recognized for its expertise in heart and vascular care, cancer care, orthopedic, and arthritis treatment, neurologic and neurosurgical care, women's health, and virtually every other area of adult medicine. BWH is the second largest NIH-funded hospital in the country, and has been home to pioneering studies and many firsts, including organ transplantation and mitral valve surgery. Along with its modern inpatient facilities in the heart of Boston's Longwood Medical Area, BWH provides seamless care across an extensive network of outpatient services and clinics, neighborhood primary care health centers, and state-of-the art diagnostic and treatment centers operating in 120 countries around the world.
Thetis Pharmaceuticals LLC, a biopharmaceutical company, develops immuno-resolving therapeutic solutions for treatment of inflammatory bowel diseases. The company’s offerings treat inflammation and promote tissue regeneration. Its HEALER technology platform unlocks potent pharmacology of lipids as new and patented molecules for oral inflammatory bowel disease (IBD) therapy. Thetis Pharmaceuticals LLC was founded in 2011 and is based in Branford, Connecticut.
Shamir Medical Centre is an advanced clinic for twin mothers whose pregnancies will receive tests outside of the health basket at no cost, such as a non-invasive blood test for chromosomal abnormalities, a preeclampsia test, a screening test to find and prevent premature birth, along with a variety of other recognized tests during pregnancy, like the nuchal test. The clinic offers one-on-one or group parent education. The sessions will be held without the kids present.
Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes.
UMMS was founded in 1962 to provide affordable, high-quality medical education to state residents and to increase the number of primary care physicians practicing in underserved areas of the state. Consistently ranked by U.S.News & World Report as one of the leading medical schools in the nation for primary care education.
Capillary Biomedical is a medical device startup developing technologies for diabetes management. They aim to dramatically simplify glucose monitoring and insulin delivery, reducing the burden on both patients and the overall healthcare system. The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA.
DreaMed Diabetes, Ltd. is an Israeli company founded in 2014 that specializes in developing innovative solutions for diabetes treatment and management. The company is known for its Glucositter, a closed-loop insulin delivery system designed to monitor glucose levels in real-time and adjust insulin delivery accordingly. DreaMed Diabetes has made significant advancements in the field, including the commercialization of the first artificial pancreas technology and becoming the first company to receive FDA clearance for a decision support system that integrates data from continuous glucose monitors and insulin pumps. Its Advisor Pro software, developed by diabetes professionals, utilizes artificial intelligence to enable healthcare providers to quickly analyze patient data and recommend optimal treatment plans. This technology facilitates frequent insulin titration adjustments and online monitoring, ultimately improving patient outcomes by lowering A1C levels and reducing complications. DreaMed Diabetes aims to provide patient-centered care, ensuring that all individuals with diabetes receive high-quality treatment regardless of their location or healthcare provider.
Tidepool is a United States-based company that provides an analytics platform designed to assess and track the psychological characteristics of internet job seekers. By utilizing advanced scientific techniques and patented technology, Tidepool offers interactive games that help users gain insights into how their personality, thinking, and mood affect daily performance. The platform allows users to engage with the content in just a few minutes daily, making it both accessible and enjoyable. Additionally, Tidepool plans to integrate with "quantified self" devices, such as fitness trackers, further enhancing its ability to provide personalized insights.
Biorasis, established in December 2007, focuses on developing needle-implantable biosensors for real-time, continuous monitoring of various bio-analytes. Initially aimed at commercializing a miniaturized sensor platform from UCONN and OSCI for glucose monitoring, the company is expanding its technology to track other critical metabolites associated with disorders such as cardiovascular issues, cancer, liver and kidney abnormalities, stroke, and epilepsy. Biorasis's biosensors enable effective diabetes management and enhance metabolic monitoring for drug research and development, allowing healthcare professionals to minimize tissue damage during implantation procedures.
Beginning in 1993, Avera offered eCARE Specialty Clinic services to rural, frontier and critical access hospitals that were part of the Avera Health system. Ten years later, Avera eCARE expanded to provide eCARE ICU, the first 24-hour, on-demand service that allows staff at partner facilities to connect virtually via a video and audio call for immediate assistance from board-certified providers. In addition, Avera eCARE delivered 24/7 access to a wide range of medical specialists and referrals to specialty care for a growing number of underserved populations and communities. Then, in 2009, through a grant from The Leona M. and Harry B. Helmsley Charitable Trust, Avera eCARE launched eCARE Emergency and eCARE Pharmacy for all of Avera’s rural hospitals. Additional funding from the Helmsley Charitable Trust and other sources allowed expansion to over 200 Avera facilities across eight states and the ability to serve partners outside Avera Health. By 2012, Avera eCARE services were available for long-term care and correctional facilities. At Avera eCARE, their telemedicine professionals work together 24/7 in the eHELM, their virtual hospital hub, also created in 2012 with the assistance of the Helmsley Charitable Trust. By staffing their central facility around the clock, their partners and patients benefit from the multidisciplinary collaboration of medical specialists within their telemedicine teams 24/7/365.
Zucara Therapeutics Inc. is focused on developing innovative therapeutics aimed at preventing hypoglycemia in patients with diabetes. Founded in 2014 and based in Toronto, Canada, with an additional office in Vancouver, the company is working on a once-daily treatment that targets somatostatin type 2 receptors in the pancreas. This pre-clinical therapy aims to regulate hormone levels that are often uncontrolled in Type 1 diabetes, thereby preventing dangerous drops in blood sugar and restoring natural glucose levels. Zucara's approach offers a significant advantage over existing treatments, which typically only address hypoglycemia after it occurs, thereby enhancing diabetes management and improving patient outcomes. The therapeutic is designed to be administered via subcutaneous injection, addressing the serious health risks associated with low blood sugar episodes.
Cody Regional Health is focusing on putting the patient first. Located in Cody, Wyo., their hospital serves as a primary, full-service medical center to communities throughout the Big Horn Basin. They also have an adjacent Long Term Care Center licensed for 94 beds and a 20-bed chemical dependency center. The Hospital has adopted the Planetree philosophy as a model of health care. The Planetree model strives to enhance patient comfort by personalizing, humanizing and demystifying the health care experience.
Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes.
Salk Institute for Biological Studies conducts research on molecular biology and genetics, neurosciences, and plant biology. The research is conducted under the guidance of 59 faculty investigators and more than 850 scientific staff, including visiting scientists, postdoctoral fellows, and graduate students. The institute’s operates to identify therapies and treatments for a range of diseases such as cancer, AIDS, Alzheimer's disease, cardiovascular disorders, anomalies of the brain, and birth defects. Six key areas represent strategic research priorities: chemistry and proteomics, stem cell biology, cell biology, regulatory biology, metabolic research, and computational and theoretical biology. The Institute has trained more than 2,700 scientists, out of which five have won Nobel prizes. Salk is home to nine Howard Hughes Medical Investigators and 14 members of the National Academy of Sciences. NCI Cancer Center, Crick-Jacobs Center, Glenn Center for Aging Research, Helmsley Center for Genomic Medicine, Waitt Advanced Biophotonics Center, and Glenn Center for Aging Research are some of the research centers operated by Salk Institute for Biological Studies. The Salk Institute for Biological Studies was established in the 1960s by Jonas Salk and is based in California, United States.